Home › Funds › Paradigm Biocapital Advisors LP › NUVL

Paradigm Biocapital Advisors LP position in NUVL

NUVALENT INC

Paradigm Biocapital Advisors LP reported holding 5,924,433 shares of NUVL (NUVALENT INC) in its Q2 2026 13F filing — a position valued at US$731.7M, representing 13.70% of its reported portfolio and ranking #2 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed NUVL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.92M sh
Reported value held$731.67M
Portfolio Weight13.70%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's NUVL position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in NUVL in Q3 2023 at 1,638,147 shares (US$75.3M). The position peaked in Q2 2026 at 5,924,433 shares, worth US$731.7M. Across 12 filings, Paradigm Biocapital Advisors LP increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 5,924,433 shares valued at US$731.7M — an increase of 600,000 shares quarter over quarter.. Notable position changes include a 136% increase in Q4 2023.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.64M $75.31M New
Q4 2023 3.86M $283.91M Add
Q1 2024 4.18M $313.71M Add
Q2 2024 4.57M $346.81M Add
Q3 2024 5.00M $511.50M Add
Q4 2024 5.36M $419.85M Add
Q1 2025 5.27M $373.71M Reduce
Q2 2025 5.27M $402.06M Hold
Q3 2025 5.27M $455.70M Hold
Q4 2025 5.27M $530.05M Hold
Q1 2026 5.32M $545.49M Add
Q2 2026 5.92M $731.67M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NUVL and 13F data

NUVL (NUVALENT INC) is a company whose sector is not yet classified in our data. 41 other funds we track also report a position in NUVL — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$2.13B), HBK INVESTMENTS L P (US$430.2M), Deep Track Capital, LP (US$220.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NUVL

All NUVL fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held NUVL?

Paradigm Biocapital Advisors LP has disclosed NUVL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Paradigm Biocapital Advisors LP's current position in NUVL?

As of Q2 2026, Paradigm Biocapital Advisors LP holds 5.92M shares of NUVL (NUVALENT INC), valued at $731.67M, representing 13.70% of its reported portfolio and ranking #2.

Has Paradigm Biocapital Advisors LP been buying or selling NUVL?

In the latest 13F filing (Q2 2026), Paradigm Biocapital Advisors LP increased its position in NUVL. The position peaked in Q2 2026 at 5.92M shares.

Which other funds hold NUVL?

Other major institutional holders of NUVL include DEERFIELD MANAGEMENT COMPANY, L.P., HBK INVESTMENTS L P, Deep Track Capital, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.